Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/365026


Advances in Point-of-Care Technologies (Technical Insights)


Description: Point-of-Care Testing Industry to Dispel False Impression about the Costs and Accuracy of its Services

Point-of-care (PoC) industry participants are working hard on dispelling the incorrect notion that PoC testing is less accurate, more expensive, and more difficult to manage than testing in central laboratories. This is an uphill task and these companies have to leverage the results of clinical studies on PoC along with their market performance to achieve this goal. The companies should promote PoC instruments that provide results, which are as accurate and reliable as those obtained from laboratories. Further, PoC manufacturers must demonstrate the cost-effectiveness of these products to physicians and patients to get rid of end-user apprehensions. Device makers also need to channelize substantial resources to develop such user-friendly, accurate, and cost-effective devices to win end-users confidence.

This Technical Insights study provides an overview of advances in PoC technologies. It presents technology and application viewpoints, examines the emerging minimally and noninvasive blood glucose monitoring solutions, blood gas analyzers with new tests, and rapid tests that combine the human immunodeficiency virus (HIV) and the hepatitis C virus (HCV). The research service enables companies to align their positioning strategies to benefit from the emerging technologies.

PoC Testing Provides Real-time Results on Multi-assay Platforms

The medical community is slowly buying into the ability of PoC tests to provide real-time results when compared to those conducted in laboratories. PoC testing helps provide better patient care by aiding physicians in decision making during emergencies, says the analyst of this research service. This is further complemented by their ability to carry out multiple assays such as blood gases, electrolytes, chemistries, coagulation, hematology, glucose, and cardiac markers simultaneously.

Various technological innovations are further assisting the creation of multi-assay platforms for concurrent testing of various diseases. These platforms not only save time and provide reliable results but also offer cost benefits. Technological innovations such as glucose monitoring systems that are minimally invasive, or even non-invasive, and do not require any kind of patient preparation are expected to go a long way in popularizing PoC technologies. These developments make PoC testing simple to perform and painless.

Central Laboratories Pose Stiff Competition to PoC Manufacturers

Laboratories are firmly established testing points and they pose the biggest competition to the PoC industry. These laboratories maintain that PoC testing cannot match laboratory testing in terms of cost and accuracy and this approach is curtailing the growth of PoC technologies. To counter this restraint, PoC test manufacturers have to publicize their new systems that are either portable, handheld units or are modular and fit into bedside monitors. The latter type can even incorporate the arterial blood gas (ABG) results into the patient's record.

Although, intensive research and development have helped add more tests to the PoC platform, scientists are now facing the challenge of conducting the optimal number of tests from a single blood sample. It has taken a while for chemistry and immunochemistry to be integrated into a single platform for central laboratory testing using serum or plasma, notes the analyst. It will be interesting to see how quickly manufacturers can replicate the same for PoC.


Contents: 1. Executive Summary

- 1. Scope and Methodology

- - 1. Scope

- - 2. Methodology

- 2. Key Findings

- - 1. Noteworthy Emerging Technologies

- - 2. Noteworthy Applications

2. Technology and Applications Viewpoint

- 1. Technology Primer

- - 1. Blood Glucose Testing

- - 2. Blood Gas/Electrolyte Testing

- - 3. Infectious Disease Testing

- - 4. Pregnancy Testing

- - 5. Drug of Abuse Testing

- - 6. Urinalysis

- 2. Technology and Application Analysis

- - 1. Application Analysis and Trends

- - 2. Analysis and Ranking of Application Segments

- 3. Assessment of Stakeholder Innovations in Companies and Universities

- - 1. Noteworthy Innovation at Key Companies

- - 2. Noteworthy Innovation at Key Academic and Government-related Institutions

- 4. Influential Market Factors

- - 1. Mergers & Acquisitions

- - 2. Regulatory Issues and Standards

- - 3. Industry Trends

3. Technology Adoption Factor Analysis

- 1. Key Challenges

- - 1. Multiple Assay Platforms

- - 2. Cost-effectiveness

- - 3. Perception

- - 4. Ease of Usage

- - 5. Personnel Training

- - 6. Partnerships

- 2. Key Drivers and Restraints

- - 1. Drivers
- - - a. Government
- - - b. Industry
- - - c. Market
- - - d. Real-time Results
- - - e. Multiassay Platforms
- - - f. Innovations

- - 2. Restraints
- - - a. Capital Intensive
- - - b. Central Laboratories
- - - c. Cheaper/Poor Quality Tests
- - - d. Reimbursement
- - - e. Regulations

4. Assessment of Innovation and Opportunities

- 1. Innovative Developments in Companies (North America)

- - 1. i-Stat1 Handheld Analyzer based on Microfabrication of Sensors

- - 2. Unique Coulometry Technology for Abbott's FreeStyle Blood Glucose Monitoring System

- - 3. A New Generation of AccuChek Inform System Planned for Hospitals-- 4. IMI Medical's PREVU Skin Sterol Test for PoC

- - 5. LifeScan's OneTouch UltraSmart Glucose Monitoring System

- - 6. Cancer Detection Instrument to Define Tumor Margins at PoC

- - 7. Nova Biomedical's Third-Generation of Critical care Blood Analyzers

- - 8. MedMira's Rapid HIV Tests based on Flow-through Membrane Technology

- - 9. Saliva-based Tests Expected to grow in Drug of Abuse

- - 10. Spectral's Focus on Cardiac Markers for PoC Testing

- - 11. Totally Noninvasive Discrete Blood Glucose System by MedOptix

- - 12. Quidel's Layered Thin Film (LTF) Platform for diagnosis of Bacterial Vaginosis

- - 13. Implantable Glucose Biosensor based on a Proprietary Hydrogel Technology

- - 14. CLIA Waived LDX Reflectance based Detection System from Cholestech

- - 15. SpectRx's Continuous Glucose Monitoring Patch and Noninvasive Cervical Cancer Detection Technology

- - 16. An Oscillometric Noninvasive Device Detects Peripheral Artery Disease in Early Stages

- - 17. A Unique Proprietary Wavesense Technology with Dynamic Electrochemistry for Glucose Monitoring

- - 18. Epocal's PoC Blood Analysis Platform with Low-Cost Diagnostic Cards

- 2. Innovative Developments in Companies (Europe)

- - 1. Roche's New Generation State-of-the-art Urine Analyzer-- 2. High-End OMNI S Analyzer for Hospital PoC applications

- - 3. CoaguChek S System from Roche for On-the-Spot Coagulation Level Analysis

- - 4. A Novel Microanalyzer Technology for Blood Gas Analysis

- - 5. Trinity Biotech Expanding its Portfolio in Infectious Diseases and Respiratory Arena

- - 6. Bayer's Clinitek Status Integrating PoC and Laboratory Workflow for Urinalysis

- - 7. Platform Diagnostics' New Capillary Agglutination Technology (CAT) for Pregnancy Testing

- - 8. Axis-Shield’s Afinion for Multiple Analytes with a Unique Failsafe System

- - 9. An Immuno Assay Test for Detection of IgG Antibodies for HHV-8 lytic antigens

- 3. Innovative Developments in Companies (Asia Pacific)

- - 1. Ambri's Ion Channel Switch membrane biosensor technology for PoC

- - 2. A Glucose Monitoring Watch that combines Photoacoustics with Advanced Spectroscopy

- - 3. Hitachi Developing a Monitoring Device that Uses Body's Metabolism to Determine Glucose Levels

- - 4. Cartridge-based Blood Gas Analyzers from Trivitron

- 4. Innovative Developments in Universities

- - 1. A Microneedle-based Continuous Glucose Monitor from University of California

- - 2. Sliver-Sensor from Case Western Reserve University for Diabetics-- 3. Vanderbilt University and Pria Diagnostics Collaborate to Develop a Unique Device for Detection of Infectious Diseases

- - 4. University of Colorado Developing a Flu Chip for Diagnosing Respiratory Illnesses

- - 5. Researchers at Mississippi State University Develop a Breath-Analyzer for Detection of Diabetes

- - 6. Singapore's Institute of Bioengineering and Nanotechnology develops a Biochip for Early Detection of Cancer at PoC

- - 7. University of Maryland's Breakthrough in Developing Contact Lenses for Monitoring Glucose-- 8. Scientists at Northwestern University Develop a New Test for Early Detection of Alzheimer's Disease

- - 9. Laser Beam with a Polarizing Lens for Blood Glucose Monitoring by an Indiana Teen

- 5. Technology Transfer Opportunities

- - 1. Bacterial Infection Diagnosis

- - 2. Saliva Rapid Assay test

- - 3. Optical Detection Technology for PoC Tests

- - 4. Noninvasive diagnostic tool for Diabetes testing

5. Analysis of Funding Sources

- 1. Venture Capital Funding

- - 1. Funding Companies 1

- - 2. Funding Companies 2

- 2. Other Funding

- - 1. Government

- - 2. Other Agencies

6. Patents; Contacts and Glossary

- 1. Patents

- - 1. Patents 1

- - 2. Patents 2

- 2. Contacts and Glossary

- - 1. Contacts-- 2. Glossary

7. Frost & Sullivan 2005 Science and Technology Awards

- 1. Technology Innovation Award

- - 1. Award Description

- - 2. Award Recipient

- 2. Excellence in Technology Award

- - 1. Award Description

- - 2. Award Recipient

- 3. Product Leadership Award

- - 1. Award Description

- - 2. Award Recipient

8. Critical Reference Tables

- 1. Decision Support Database Tables

- - 1. Incidence of Diabetes--World (1999-2006)

- - 2. Prevalence of Diabetes--World (1999-2006)

- - 3. Incidence of Myocardial Infarction--World (1999-2006)

- - 4. Incidence of Hepatitis A--World (1999-2006)

- - 5. Incidence of Hepatitis B--World (1999-2006)

- - 6. Prevalence of HIV--World (1999-2006)

- - 7. Number of Diagnostic Testing Facilities--USA (1999-2007)




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/365026

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 12/02/2012 17:17:45
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Advances in Point-of-Care Technologies (Technical Insights)
Web Address:
http://www.researchandmarkets.com/reports/365026
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Site License €3,821.00
Electronic (PDF) - Enterprisewide €4,968.00
Electronic and Hard Copy (PDF) - Enterprisewide €5,350.00 + EUR€ 50.00 Shipping/Handling *
Electronic and Hard Copy (PDF) - Site License €4,204.00 + EUR€ 50.00 Shipping/Handling *
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 12/02/2012 17:17:45

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)